Skip to Main Content
Qurgen Qurgen
Menu Button

Apr. 2026

Brand Icon
  • April of 2026, no infusion related reaction (IRR)  has occurred during the 48-hour continuous infusion by pump, this indicates a significantly enhanced safety of SON-DP treatment. 

Recent news & press

2026
Prof Wang was invited to attend Tigermed's ASCO Pre-Event Webinar as a Speaker to introduce...
Learn More
Mar. 2026
Qurgen has completed SON-DP treatment for multiple late-stage solid tumor patients for over 18-months at low dose levels...
Learn More